CCM
ACET icon

Consonance Capital Management’s Adicet Bio ACET Stock Holding History

Consonance Capital Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-64,088
Closed -$10.6M – 18
2021
Q2 		$10.6M Sell
64,088
-11,966
-16% -$2.44M 1.27% 17
2021
Q1 		$15.9M Buy
+76,054
New +$17.5M 1.7% 21

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Consonance Capital Management's ACET Position: Q3 2021 in Review

Consonance Capital Management sold out of Adicet Bio (ACET) in Q3 2021, closing a stake of 64,088 shares — an estimated $10.6M sold.

Consonance Capital Management first reported a position in ACET in Q1 2021 and held it in 2 quarters. The position peaked at $15.9M in Q1 2021. 58 funds tracked by Wall St. Rank hold ACET as of Q3 2021.

  • Consonance Capital Management reported no remaining Adicet Bio position as of Q3 2021 after selling out during the quarter.
  • Consonance Capital Management sold 64,088 Adicet Bio shares in Q3 2021, an estimated $10.6M.
  • Consonance Capital Management first reported a position in Adicet Bio in Q1 2021 and held it in 2 quarters.
  • Consonance Capital Management's Adicet Bio position peaked at $15.9M in Q1 2021.
  • 58 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2021.

Based on Consonance Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.